- Home
- ACET vs AUBN Comparison
ACET vs AUBN Comparison
Compare ACET & AUBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACET
- AUBN
- Stock Information
- Founded
- ACET 1947
- AUBN 1907
- Country
- ACET United States
- AUBN United States
- Employees
- ACET N/A
- AUBN N/A
- Industry
- ACET Biotechnology: Pharmaceutical Preparations
- AUBN Major Banks
- Sector
- ACET Health Care
- AUBN Finance
- Exchange
- ACET Nasdaq
- AUBN Nasdaq
- Market Cap
- ACET 83.2M
- AUBN 74.7M
- IPO Year
- ACET N/A
- AUBN 1995
- Fundamental
- Price
- ACET $0.89
- AUBN $21.30
- Analyst Decision
- ACET Buy
- AUBN
- Analyst Count
- ACET 6
- AUBN 0
- Target Price
- ACET $6.00
- AUBN N/A
- AVG Volume (30 Days)
- ACET 414.2K
- AUBN 1.7K
- Earning Date
- ACET 03-06-2025
- AUBN 04-23-2025
- Dividend Yield
- ACET N/A
- AUBN 5.07%
- EPS Growth
- ACET N/A
- AUBN 359.14
- EPS
- ACET N/A
- AUBN 1.83
- Revenue
- ACET N/A
- AUBN $30,563,000.00
- Revenue This Year
- ACET N/A
- AUBN N/A
- Revenue Next Year
- ACET N/A
- AUBN N/A
- P/E Ratio
- ACET N/A
- AUBN $11.77
- Revenue Growth
- ACET N/A
- AUBN 31.96
- 52 Week Low
- ACET $0.74
- AUBN $16.48
- 52 Week High
- ACET $2.43
- AUBN $25.40
- Technical
- Relative Strength Index (RSI)
- ACET 55.27
- AUBN 55.52
- Support Level
- ACET $0.74
- AUBN $20.65
- Resistance Level
- ACET $0.81
- AUBN $21.75
- Average True Range (ATR)
- ACET 0.06
- AUBN 0.33
- MACD
- ACET 0.01
- AUBN 0.11
- Stochastic Oscillator
- ACET 71.29
- AUBN 86.33
About ACET Adicet Bio Inc.
Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Its lead product candidate, ADI-001, a first-in-class allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, is being developed for the potential treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma. Their pipeline also includes its lead preclinical candidate, ADI-270, an armored gamma delta CAR T cell product candidate targeting renal cell carcinoma, with potential for other CD70+ solid tumor and hematological malignancies indications.
About AUBN Auburn National Bancorporation Inc.
Auburn National Bancorp Inc operates as a bank holding company, which offers checking, savings, transaction deposit accounts and certificates of deposit, and is an active residential mortgage lender in its primary service area. The Bank's primary service area includes the cities of Auburn and Opelika, Alabama and nearby surrounding areas in East Alabama, predominantly in Lee County. The Bank also offers commercial, financial, agricultural, real estate construction and consumer loan products and other financial services. The Bank also provides automated teller machine (ATM) services in East Alabama and operates ATM machines. The Bank offers Visa Checkcards, which are debit cards. The Bank offers online banking, bill payment and other electronic banking services through its Internet website.